Sector News

Allergan to buy medical device company Keller Medical Inc.

June 8, 2017
Life sciences

Allergan PLC said early Wednesday that it plans to buy privately-held medical device company Keller Medical Inc., which developed a funnel used during breast surgery procedures.

The Keller Funnel, which helps plastic surgeons guide implants into the surgical pocket and reduces the risk of implant contamination, is “a natural complement to our world-class plastic surgery and regenerative medicine business,” said Senior Vice President of Medical Aesthetics David Moatazedi.

Plastic surgery and cosmetics has become a key business area for Allergan, with its aesthetics business — which includes Botox among other products — seen as one of its key assets. Allergan spent nearly $2.5 billion earlier this year to buy body-contouring company Zeltiq Aesthetics. Allergan shares were not active in premarket trade. Shares have dropped 4.7% over the last three months, compared with a 2.6% rise in the S&P 500.

By Emma Court

Source: Market Watch

comments closed

Related News

May 26, 2024

From pharma to food: Vitafoods 2024 highlights

Life sciences

Beyond the vibrant displays and insightful discussions at Vitafoods 2024 stood the backdrop of a rapidly expanding nutraceutical market. With consumers increasingly seeking preventive healthcare solutions and natural alternatives to traditional medicine, the global nutraceutical industry has witnessed remarkable growth in recent years.

May 26, 2024

Genmab completes acquisition of ProfoundBio

Life sciences

Genmab has completed its $1.8 billion acquisition of ProfoundBio, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADC)s and ADC technologies for the treatment of cancers.

May 26, 2024

Merck to acquire life science company Mirus Bio

Life sciences

Merck has agreed to acquire US life sciences company Mirus Bio for $600 million (around €550 million) from Gamma Biosciences, a life sciences platform established by global investment firm KKR. Based in Madison, Wisconsin, Mirus Bio is a specialist in the development and commercialization of transfection reagents.

How can we help you?

We're easy to reach